Marios Panagiotou (National and Kapodistrian University of Athens, Athens, Greece) discusses the background and findings of his late-breaking presentation entitled: Daily physical activity in patients with severe eosinophilic asthma and the effect of anti-IL5 therapy.
1. What treatment response criteria have been used in previous studies of anti-interleukin-5 (IL-5) antibodies in patients with severe eosinophilic asthma? (0:12)
2. Why was daily physical activity (DLA) chosen as a clinical endpoint in your recent study? (0:47)
3. Could you tell us a little about the study design and how DLA was measured? (1:52)
4. What have been the preliminary findings of this study? (3:12)
5. What further studies are planned? (4:39)
Speaker disclosure: Marios Panagiotou has nothing to disclose in relation to this video interview.
Filmed at the European Respiratory Society (ERS) International Congress 2018, Paris, France, September 2018.
Related Videos In Asthma
Michael Wechsler, ERS 2020 – Dupilumab in the LIBERTY ASTHMA TRAVERSE Trial
We discuss with Prof. Michael Wechsler (National Jewish Health, Denver, CO, USA) the clinical evidence supporting the use of dupilumab in patients with asthma and specifically the major findings from the long-term safety evaluation of dupilumab in the LIBERTY ASTHMA TRAVERSE trial (NCT02134028). Questions 1. What are the major unmet needs in the biologic treatment […]
Richard van Zyl-Smit, ERS 2020 – Optimising Inhaled Therapies for Asthma
Richard van Zyl-Smit (University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa) kindly took the time to speak with us about maximising the benefit of inhaler therapy and recent development being made in this field. Questions What are the major unmet needs in the use of inhaled therapies for the control of […]
Peter J Barnes, ERS 2020 – Smart Inhalers for COPD and Asthma
During the ERS International Congress 2020, it was great to catch up with our Editorial Board member, Prof. Peter J Barnes (Imperial College, London, UK), to continue the discussion around Smart Inhalers and how they could help optimise inhaler use in patients. Questions How common is poor adherence and inhaler technique in people with asthma […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!